CannaVcell enhances its IR activities by hiring INN and Flinnwest services

Vancouver, British Columbia--(Newsfile Corp. - June 25, 2019) - Canna-V-Cell Sciences Inc. (CSE: CNVC) ("CannaVcell") With the increase in its confidence of achieving the goals of the Cannabis biofarming development program, CannaVcell is hiring both Flinnwest and INN services. "This increase in confidence requires a further enhancement in the communication with the investment community" said Dr. Zaki Rakib the CEO while adding "as we are getting closer to demonstrate the feasibility and viability of the revolutionary biofarming technology for Cannabis, it becomes increasingly important to engage with the largest possible investors base for explaining the advantages of CannaVcell's value proposition and the superiority of its technology".

"INN is pleased to assist CannaVcell to educate investors about the advantages of its biofarming technology," said Nick Smith, INN CEO. "Investors ready to take the next step can then directly connect with CannaVcell."

"FlinnWest Solutions would like to express their excitement to be working along side CannVcell assisting with their Digital Marketing and IR requirements "- Grady Flinn, CEO FlinnWest Solutions.

About INN

The Investing News Network® (INN) is a leading online source for investment news, market education and connections to trusted companies. Established in 2007, our network now includes 46 channels dedicated to covering investment opportunities within the Resource, Cannabis, Technology and Life Science sectors. Investors choose us because of our Editorial Team's reputation for providing independent, trusted reporting on what's driving today's markets. Public companies choose INN because even in challenging markets we consistently deliver results, build brand awareness and connect them with informed investors.

About Flinnwest Solutions

We're a passionate team of designers, engineers, digital strategists, writers, producers, code artists, and video creators at the service of our client to help them achieve brand awareness. "FlinnWest Solutions has the toolbox to make your challenges their solution" - Grady Flinn, CEO FlinnWest Solutions

About Canna-V-Cell Sciences Inc.

Based in Vancouver BC, Canna-V-Cell Sciences Inc. (CNVC) is the exclusive Cannabis worldwide licensee of the proprietary and patent protected BioHarvest technology. It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. By adopting this technology and building adequate cells production capacity, Canna-V-Cell's objective is to become the leading supplier of Cannabis for both the medicinal and recreational legal use.

Canna-V-Cell Sciences Inc.
Dr. Zaki Rakib
Founder & CEO

For further information, please contact:
Email: inquiries@cannavcellsciences.ca
Local Phone: 604.373.4774
Toll Free: 833.727.4774

Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things, risks and uncertainties relating to the fact that the Companywould require additional funds in order to construct a commercial biochamber facility and risks related to the adaption of the BioHarvest technology to cannabis. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

Neither Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/45850